Skip to main content
. 2019 Sep 10;20(18):4463. doi: 10.3390/ijms20184463

Figure 4.

Figure 4

KIT Assay biomarker modeling of progression status after one year of treatment. Modeling was performed on endpoint, midpoint, and baseline biomarker data on either (A) the set of KIT Assay biomarkers or (B) proteinuria alone. The y-axis shows the probability of progression as determined by a nominal logistic regression model.